Surgical treatment of tracheal stenosis during Covid-19 era: a single-center experience and lessons learnt on the field - Scorecard - MDSpire

Surgical treatment of tracheal stenosis during Covid-19 era: a single-center experience and lessons learnt on the field

  • By

  • Diana Bacchin

  • Vittorio Aprile

  • Alessandra Lenzini

  • Stylianos Korasidis

  • Maria Giovanna Mastromarino

  • Alessandro Picchi

  • Olivia Fanucchi

  • Alessandro Ribechini

  • Marcello Carlo Ambrogi

  • Marco Lucchi

  • July 17, 2023

  • 0 min

Share

Clinical Scorecard: Management of Tracheal Stenosis through Surgical Intervention in the Context of Covid-19: Insights from a Single-Center Study

At a Glance

CategoryDetail
ConditionBenign laryngo-tracheal stenosis, often acquired post prolonged invasive mechanical ventilation
Key MechanismsIschemic injury of tracheal mucosa from cuff pressure causing circumferential scarring and narrowing
Target PopulationPatients with tracheal stenosis post prolonged IMV, including Covid-19 and non-Covid-19 patients
Care SettingMultidisciplinary thoracic surgery center with ICU and surgical facilities

Key Highlights

  • Prolonged (>14 days) invasive mechanical ventilation is the main cause of acquired tracheal stenosis.
  • Covid-19 ICU patients often require longer ventilatory support and have increased incidence of post-IMV tracheal stenosis.
  • Surgical resection with primary end-to-end anastomosis is performed after failure of conservative endoscopic treatments.

Guideline-Based Recommendations

Diagnosis

  • Perform fiberoptic bronchoscopy to assess stenosis features including morphology, location, length, lumen, and cartilaginous involvement.
  • Conduct neck and thorax CT scan with multiplanar reconstructions to evaluate anatomical relationships.
  • Exclude patients with tracheo-esophageal fistula from standard surgical analysis due to complexity.

Management

  • Primary endoscopic treatments (laser disobstruction, balloon dilation, stent placement) may be attempted initially.
  • Surgical intervention involves tracheal resection and primary end-to-end anastomosis under general anesthesia with intraoperative bronchoscopy.
  • Post-Covid-19 patients should be clinically healed and PCR negative before surgery; ideally wait at least 2 months post-IMV when possible.
  • Use synthetic monofilament absorbable sutures for anastomosis; place chest-to-chin stitches to avoid neck extension.

Monitoring & Follow-up

  • Perform fiberoptic bronchoscopy immediately post-surgery and on postoperative days 3 and 7 or as clinically indicated.
  • Assess anastomosis patency intraoperatively and postoperatively via bronchoscopy.
  • Avoid chronic steroid therapy postoperatively; short-term high-dose corticosteroids may be used selectively.

Risks

  • Potential for anastomotic complications requiring close bronchoscopic monitoring.
  • Increased complexity and risk in patients with tracheo-esophageal fistula (excluded from this study).

Patient & Prescribing Data

Patients undergoing surgery for benign tracheal stenosis during the Covid-19 pandemic, including post-Covid-19 and non-Covid-19 groups

Surgical outcomes analyzed retrospectively; post-Covid-19 patients require careful timing and multidisciplinary evaluation before surgery.

Clinical Best Practices

  • Multidisciplinary preoperative assessment involving thoracic surgeon, bronchial endoscopist, anesthesiologist, and pneumologist.
  • Use intraoperative fiberoptic bronchoscopy to guide intubation and confirm stenosis margins.
  • Extubate patients immediately after surgery and monitor airway patency closely with scheduled bronchoscopies.
  • Place chest-to-chin stitches to prevent neck extension and protect anastomosis integrity.
  • Delay surgery post-Covid-19 infection until clinical healing and negative PCR testing to reduce complications.

References

Original Source(s)

Related Content